Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Exactech
Autograft (bone taken from one part of the body and placed in another site on the same individual) has long been considered the gold standard for lumbar spine fusion procedures. Unfortunately, there are complications involved with autograft harvest such as donor site morbidity, increased operating time, and limited supply. Therefore, the use of allograft (bone taken from one body and placed into another individual) as a graft extender has become an acceptable practice, especially in fusions of more than one level where larger quantities of graft material are needed.
In this study, comparisons will be made between patients who are randomized to having fusion with an allograft material (Optecure, Exactech, Inc.) mixed with an autograft to those patients who are randomized to having fusion with autograft alone.
Age
21–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patient is indicated for primary lumbar fusion of 1 or 2 segments, L2 to S1
Patient is willing to be blindly randomized to treatment or control and remain blinded for 2 years of follow-up
Patient is at least twenty-one (21) years of age
Patient is expected to survive at least 2 years beyond surgery
Patient is willing to participate by complying with pre- and postoperative visit requirements, including: completion of questionnaires, functional performance tests, and radiographs/CT scan
Patient is willing and able to review and sign a study Informed Consent form
You may not be if
Patient has a mental or physical condition that would invalidate evaluation results
Patient is pregnant
Patient is a prisoner
Patient has a systemic infection or infection at the proposed surgical site
Patient has osteopenia, osteoporosis, or osteomalacia to a degree that spinal instrumentation would be contraindicated
Patient has a disease of bone metabolism
Patient is undergoing chemotherapy or radiation treatment
Patient is currently involved in a study of another product for a similar purpose
Patient requires post-op management with nonsteroidal anti-inflammatory drugs (NSAIDs)